REGULATED PRESS RELEASE published on 08/28/2025 at 07:00, 11 months 13 days ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, marking a significant milestone in developing therapies for muscle loss in aging individuals Biophytis Sarcopenia Phase 3 EMA Belgian Regulatory Approval
PRESS RELEASE published on 08/28/2025 at 06:59, 11 months 13 days ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, enabling patient enrolment in Belgium and collaboration with European centers Biophytis Sarcopenia Phase 3 EMA Approval Belgian Regulatory Approval
BRIEF published on 08/05/2025 at 23:05, 1 year ago Biophytis Secures €1 Million Non-Dilutive Bond Financing Biophytis Bond Financing Shareholder Impact Non-dilutive OBA101 Program
REGULATED PRESS RELEASE published on 08/05/2025 at 23:00, 1 year ago Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million Biophytis secures a non-dilutive bond financing line of up to €1 million with Hexagon Capital Fund to support OBA101 program development and strengthen cash position Biophytis Financing Hexagon Capital Fund OBA101 Program Non-dilutive Bond
PRESS RELEASE published on 08/05/2025 at 22:59, 1 year ago Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million Biophytis secures a non-dilutive bond financing line of up to €1 million from Hexagon Capital Fund. The bonds, with 12% annual interest rate, will mature in 24 months and may be repaid in shares Biophytis Hexagon Capital Fund Non-dilutive Bond Financing 12% Interest Rate Repayment In Shares
BRIEF published on 07/30/2025 at 07:05, 1 year ago Biophytis Joins Silver Innov' to Boost Silver Economy Initiatives Biophytis Healthcare Innovation Longevity Sarcopenia Silver Innov'
REGULATED PRESS RELEASE published on 07/30/2025 at 07:00, 1 year ago Biophytis Joins Silver Innov', an Incubator Dedicated to the Silver Economy Biophytis relocates to Silver Innov' in Paris, embracing the silver economy ecosystem for innovation and healthcare in aging, strengthening academic and clinical research collaborations Innovation Biophytis Healthcare Silver Innov Aging
BRIEF published on 07/16/2025 at 07:05, 1 year ago Biophytis Achieves Legal Victory in Court of Cassation Biophytis Legal Victory Court Of Cassation Negma Group Convertible Bond Dispute
REGULATED PRESS RELEASE published on 07/16/2025 at 07:00, 1 year ago Biophytis Wins Major Legal Victory Before the French Court of Cassation Biophytis celebrates a major legal win at the French Court of Cassation validating its position in the dispute with Negma Group, a landmark decision protecting the company's interests Biophytis Legal Victory Court Of Cassation Negma Group Landmark Ruling
PRESS RELEASE published on 07/16/2025 at 06:59, 1 year ago Biophytis Wins Major Legal Victory Before the French Court of Cassation Biophytis celebrates major legal win as French Court of Cassation rules in its favor against Negma Group, marking a turning point in the litigation and validating the company's legal position Biophytis Litigation Legal Victory Negma Group French Court Of Cassation
Published on 08/11/2026 at 00:40, 3 hours 21 minutes ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 3 hours 36 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 4 hours 26 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 4 hours 31 minutes ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/10/2026 at 23:25, 4 hours 36 minutes ago Ur-Energy Reports Second Quarter 2026 Results
Published on 08/10/2026 at 22:15, 5 hours 46 minutes ago Amrize Files Form 10-Q for Second Quarter 2026
Published on 08/10/2026 at 22:05, 5 hours 56 minutes ago Immunic Appoints Elena Ridloff to Board of Directors
Published on 08/10/2026 at 20:24, 7 hours 36 minutes ago EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 8 hours 26 minutes ago Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 18:29, 9 hours 31 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 08/10/2026 at 18:00, 10 hours 1 minute ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 16 hours 7 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 16 hours 24 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 18 hours 39 minutes ago Number of shares and voting rights - July 2026 (In French only)
